Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn

    2026-05-02

    Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Technical Guidance for Laboratory Workflows

    What This Product Solves

    Proteolytic degradation during protein extraction and analysis can compromise the integrity, yield, and interpretability of experimental data. This is especially problematic when studying post-translational modifications or working with labile proteins. The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses these challenges by providing broad-spectrum inhibition of serine, cysteine, acid proteases, and aminopeptidases without introducing EDTA. The absence of EDTA ensures compatibility with workflows sensitive to divalent cations (e.g., kinase assays, phosphorylation analysis, and certain enzyme assays), where chelation would be undesirable.

    It is supplied as a 200X concentrate in DMSO, streamlining workflow setup and minimizing freeze-thaw cycles. This product is appropriate for Western blotting, co-immunoprecipitation, pull-down assays, immunofluorescence, immunohistochemistry, and other applications requiring protein degradation prevention (internal article).

    Protocol Parameters

    • Protein Extraction (General) | 1:200 dilution (200X stock; add 5 μL per 1 mL buffer) | Routine extraction of cellular or tissue proteins | Balances inhibitor effectiveness against cytotoxicity and DMSO content; validated for broad-spectrum protection | product_spec (link)
    • Cultured Cell Medium Supplementation | 1:200 dilution (add to fresh medium) | Protects secreted and intracellular proteins during prolonged incubations (up to 48 h) | Maintains inhibitor activity for up to 48 hours in medium, after which medium should be refreshed | product_spec
    • Phosphorylation Analysis (Kinase Assays) | Use EDTA-free formulation at 1:200 dilution | Ensures compatibility with cation-dependent enzymes and signaling studies | Avoids chelation artifacts that could confound phospho-state detection | product_spec
    • Western Blot Sample Prep | 1:200 to 1:400 dilution (workflow recommendation) | Adjust dilution based on protease load and sample sensitivity | Lower concentration can be used if cell line is sensitive or if protease activity is low | workflow_recommendation (internal article)

    Workflow Setup and QC Checklist

    • Stock Handling: Store the Protease Inhibitor Cocktail at -20°C. Thaw only what is needed for immediate use to prevent freeze-thaw degradation. The product is stable for at least 12 months at -20°C (source: product_spec).
    • Preparation: Vortex the stock solution briefly after thawing. Add the inhibitor directly to chilled lysis buffers or culture media immediately before use.
    • Dilution: Use a minimum 1:200 dilution for most applications. For particularly sensitive cell lines or low-protease samples, consider pilot titration (e.g., 1:200, 1:400) to optimize preservation and minimize cytotoxicity.
    • Compatibility: Confirm that downstream assays (e.g., kinase, phosphatase activity) are compatible with DMSO and the absence of EDTA.
    • QC Controls: Include no-inhibitor controls to monitor baseline proteolysis. Validate inhibitor performance by assessing cleavage-sensitive protein markers via Western blot or activity assays.
    • Media Refresh: When used in culture medium, refresh with inhibitor-containing medium every 48 hours to maintain efficacy.

    Common Failure Modes and Fixes

    • Incomplete Protease Inhibition: If proteolysis persists, confirm correct dilution and mixing. Increase the inhibitor concentration (e.g., from 1:200 to 1:100, within cytotoxicity constraints) or supplement with additional cocktail after extended incubations (internal article).
    • Cytotoxic or Assay Interference: Excess DMSO or inhibitors may negatively impact cell viability or certain enzyme activities. Reduce the final concentration or perform procedural testing with controls to identify minimum effective dose.
    • Loss of Post-Translational Modifications: Use the EDTA-free formulation to prevent chelation and loss of divalent cation-dependent modifications (e.g., phosphorylation). Confirm lysis buffer composition matches experimental needs.
    • Precipitation or Cloudiness: Ensure the stock is fully dissolved before dilution and avoid repeated freeze-thaw cycles. Discard aliquots showing visible precipitate.

    Scope and Limitations

    • This Protease Inhibitor Cocktail is not a replacement for phosphatase inhibitors. For comprehensive protection of phospho-proteins, include recommended phosphatase inhibitors as needed.
    • Its EDTA-free composition is ideal for assays dependent on divalent cations but not suitable where metal ion chelation is required (e.g., some nucleic acid extractions).
    • While broad-spectrum, this cocktail may not inhibit all protease classes (e.g., metalloproteases). For workflows with high metalloprotease activity, supplementary inhibitors may be necessary.
    • Performance is validated for up to 48 hours in culture medium; for extended protocols, re-addition is required.

    Conclusion

    The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) offers a reliable means of preserving protein integrity in workflows where serine protease inhibition and broad-spectrum protection are required without introducing EDTA. Its compatibility with phosphorylation and cation-dependent assays, extended stability, and concentration flexibility make it well-suited for diverse laboratory protocols. For advanced, scenario-driven applications and troubleshooting, refer to detailed guidance such as Optimizing Protein Integrity: Scenario-Driven Use. Always validate protocol adjustments through pilot assays to ensure optimal protection and compatibility with your experimental system.